Results 101 to 110 of about 10,389 (214)

Neurosteroid Levels in GBA Mutated and Non-Mutated Parkinson’s Disease: A Possible Factor Influencing Clinical Phenotype?

open access: yesBiomolecules
Neurosteroids are pleiotropic molecules involved in various neurodegenerative diseases with neuroinflammation. We assessed neurosteroids’ serum levels in a cohort of Parkinson’s Disease (PD) patients with heterozygous glucocerebrosidase (GBA) mutations ...
Francesco Cavallieri   +10 more
doaj   +1 more source

Studies on the turnover of glucocerebrosidase in cultured rat peritoneal macrophages and normal human fibroblasts

open access: yes, 1986
The kinetics of glucocerebrosidase synthesis and degradation in rat peritoneal macrophages and in human fibroblasts have been studied using conduritol B epoxide (CBE), an irreversible and specific inhibitor of mammalian glucocerebrosidase.
Das, Pijush K.   +2 more
core   +1 more source

Identification of GM1-Ganglioside Secondary Accumulation in Fibroblasts from Neuropathic Gaucher Patients and Effect of a Trivalent Trihydroxypiperidine Iminosugar Compound on Its Storage Reduction

open access: yesMolecules
Gaucher disease (GD) is a rare genetic metabolic disorder characterized by a dysfunction of the lysosomal glycoside hydrolase glucocerebrosidase (GCase) due to mutations in the gene GBA1, leading to the cellular accumulation of glucosylceramide (GlcCer).
Costanza Ceni   +10 more
doaj   +1 more source

Lectin-specific targeting of β-glucocerebrosidase to different liver cells via glycosylated liposomes

open access: yes, 1985
Galactosylated and mannosylated liposomes were more efficient in transporting liposome-entrapped β-glucocerebrosidase to liver compared to nonglycosylated liposomes.
Zirzow, Gregory C.   +4 more
core   +1 more source

Immunoelectron microscopic localization of mannose-terminal glucocerebrosidase in lysosomes of rat liver Kupffer cells.

open access: yes, 1995
Knowledge of the cellular distribution and subcellular localization of mannose-terminal glucocerebrosidase after intravenous infusion is necessary for understanding the efficacy of targeted enzyme replacement therapy for Gaucher's disease.
F S Jin, G J Murray
core   +1 more source

Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers

open access: yes, 2012
Glucocerebrosidase (GBA) gene mutations represent a strong risk factor for Parkinson disease (PD). PD penetrance in GBA mutation carriers, which represents a key issue for genetic counseling, especially for relatives of patients with Gaucher disease (GD),
Condroyer, C   +19 more
core   +1 more source

Case Report: Novel treatment approach for severe interstitial lung disease in type 3 Gaucher disease

open access: yesFrontiers in Pediatrics
Gaucher Disease Type 3 (GD3) is a rare lysosomal storage disorder characterized by both visceral and neurological involvement. Pulmonary manifestations can significantly impact prognosis and quality of life.
Vincenza Gragnaniello   +7 more
doaj   +1 more source

Rapid and long‐lasting efficacy of high‐dose ambroxol therapy for neuronopathic Gaucher disease: A case report and literature review

open access: yesMolecular Genetics & Genomic Medicine
Gaucher disease (GD) is a lysosomal storage disorder caused by a deficiency in the GBA1‐encoded enzyme, β‐glucocerebrosidase. Enzyme replacement therapy is ineffective for neuronopathic Gaucher disease (nGD).
Kanako Higashi   +28 more
doaj   +1 more source

Process for preparing exosome loading β-glucocerebrosidase, and pharmaceutical composition for use in preventing and treating Gaucher Disease containing the same as an active ingredient

open access: yes, 2020
본 발명은 GBA(β-glucocerebrosidase) 단백질을 포함하는 엑소솜(GBA:EXPLOR)을 대량으로 제조하는 방법, 상기 엑소솜 제조에 사용될 수 있는 엑소솜 제조용 벡터, 상기 방법으로 제조된 GBA(β-glucocerebrosidase) 단백질을 포함하는 엑소솜 및 이를 유효성분으로 함유하는 고셔병 치료용 약학적 조성물에 관한 것이다.
류승욱   +4 more
core   +1 more source

Glucocerebrosidase mutations in diffuse Lewy body disease

open access: yes, 2011
Clinicogenetic and pathological studies have shown that mutations of the glucocerebrosidase gene (GBA) are a risk factor for Parkinson's disease and Lewy body disorders.
Alex Rajput   +46 more
core   +1 more source

Home - About - Disclaimer - Privacy